Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Clinical trial NCT06441006 · RECRUITING

Trial details

NCT number: NCT06441006
Sponsor: University of California, San Francisco
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary Tuberculosis, Multidrug-Resistant Tuberculosis, MDR

Start date: 2025-10-03
Primary completion: 2031-08-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.